Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J Must Pay $257.6 Million Over Risperdal Marketing, Louisiana Jury Says
J&J Must Pay $257.6 Million Over Risperdal Marketing, Louisiana Jury Says
J&J Must Pay $257.6 Million Over Risperdal Marketing, Louisiana Jury Says
Submitted by
admin
on October 15, 2010 - 10:27am
Source:
Bloomberg
News Tags:
JNJ
Risperdal
antipsychotics
Headline:
J&J Must Pay $257.6 Million Over Risperdal Marketing, Louisiana Jury Says
Do Not Allow Advertisers to Use My Personal information
